1. Centre National De La Recherche Scientifique (9 from 5,089 patents)

2. Institut National De La Sante Et De La Recherche Medicale (9 from 1,744 patents)

3. Université´ D'aix-marseille (8 from 230 patents)

4. Institut Jean Paoli & Irène Calmettes (5 from 26 patents)

5. Universitè De Montpellier (3 from 280 patents)

6. Université De Reims Champagne-ardenne (2 from 27 patents)

7. Cisbio Bioassays (2 from 7 patents)

8. Institut Regional Du Cancer De Montpellier-val D'aurelle (2 from 4 patents)

9. Institut Paoli Calmettes (2 from 2 patents)

10. Other (1 from 832,891 patents)

11. Université Paris—sud (1 from 99 patents)

12. Assistance Publique Hopitaux De Marseille (1 from 14 patents)

13. Ciscio Bioassays (1 from 1 patent)

14. Centre National De La Recherche Scientifique-cnrs (67 patents)

15. Inserm (institut National De La Sante Et De La Recherche Medicale) (38 patents)

1. 12187793 - Single-domain antibody binding to the G protein alpha

2. 10385137 - Production of antibody formats and immunological applications of said formats

3. 10316315 - Methods for selecting binders by phage display and masked selection

4. 10287360 - Anti-EGFR conformational single domain antibodies and uses thereof

5. 10174117 - Anti-HER2 single domain antibodies, polypeptides comprising thereof and their use for treating cancer

6. 10174115 - Anti-mGluR2 conformational single domain antibodies and uses thereof

7. 10167345 - Antigen binding formats for use in therapeutic treatments or diagnostic assays

8. 9644033 - Protein constructs designed for targeting and lysis of cells

9. 9605257 - Methods for selecting binders by phage display and masked selection

10. 9598499 - Antigen binding formats for use in therapeutic treatments or diagnostic assays

11. 9512203 - Single-domain antibodies that bind to HIV-1 Nef with high affinity

12. 9169316 - Production of antibody formats and immunological applications of said formats

13. 8900592 - Protein constructs designed for targeting and lysis of cells